|
 |
poractant alfaThis page contains recent news articles, when available, and an overview of poractant alfa but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.For both groups, death rates were nearly 20% lower for babies treated with poractant alfa than for those treated with either beractant or calfactant." ... Free with registration - PR Newswire - AccessMyLibrary.com Lung Treatments For Premature Babies Under Study - May 8, 2007 Previous studies, comparing poractant alfa with calf-derived beractant, ... Pig-derived poractant alfa, a relative newcomer approved by the FDA in 1999, ... sciencedaily.com Preterm Infants With RDS -- Surfactant Replacement Therapies Improves... - May 12, 2007 For both groups, death rates were nearly 20% lower for babies treated with poractant alfa than for those treated with either beractant or calfactant." ... Medical News Today - Medical News Today (press release) Lung Treatments For Premature Babies Assessed By Study - May 12, 2007 Previous studies, comparing poractant alfa with calf-derived beractant, ... Pig-derived poractant alfa, a relative newcomer approved by the FDA in 1999, ... Medical News Today - Medical News Today (press release) Study assesses lung treatments for premature babies - Sep 5, 2007 Previous studies, comparing poractant alfa with calf-derived beractant, ... Pig-derived poractant alfa, a relative newcomer approved by the FDA in 1999, ... innovations report Press Release: Preterm Infants with Respiratory Distress Syndrome: … - May 7, 2007 Large multi-year, multi-hospital retrospective database analysis demonstrates RDS treatment with Curosurf(R) (poractant alfa) Intratracheal Suspension ... Pay-Per-View - PR Newswire - HighBeam Research Un leader marcato Chiesi - Sep 12, 2006 Il motivo sta nei numeri: Curosurf (poractant alfa) prodotto dal Gruppo Chiesi ... Il farmaco a base di poractant alfa è attualmente il surfattante piú ... Pharma Marketing Discovery Labs Reports First Quarter 2005 Financial Results and … - Apr 27, 2005 ..."Pediatrics" (2005) 115:1030-1038; A Multicenter, Randomized, Controlled Trial of Lucinactant Versus Poractant Alfa Among Very Premature Infants at High ... RedOrbit GlobeNewswire, Inc. - News Room - Apr 4, 2005 4 April 2005 -- A Randomized, Controlled Trial of Lucinactant Versus Poractant Alfa Among Very Premature Infants at High Risk for Respiratory Distress ... primezone.com Discovery Labs Submits Response to Second FDA Approvable Letter - Nov 28, 2007 ...against Abbott Laboratories' Survanta (beractant), Forest Pharmaceuticals' Infasurf (calfactant) and Mylan subsidiary Dey's Curosurf (poractant alfa). FDA news - FDA news (subscription) |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |